Literature DB >> 28284462

An observational study of agreement between percentage pain reduction calculated from visual analog or numerical rating scales versus that reported by parturients during labor epidural analgesia.

E Pratici1, S Nebout1, N Merbai1, J Filippova1, D Hajage2, H Keita3.   

Abstract

BACKGROUND: This study aimed to determine the level of agreement between calculated percentage pain reduction, derived from visual analog or numerical rating scales, and patient-reported percentage pain reduction in patients having labor epidural analgesia.
METHODS: In a prospective observational study, parturients were asked to rate their pain intensity on a visual analog scale and numerical rating scale, before and 30min after initiation of epidural analgesia. The percentage pain reduction 30min after epidural analgesia was calculated by the formula: 100×(score before epidural analgesia-score 30min after epidural analgesia)/score before epidural analgesia. To evaluate agreement between calculated percentage pain reduction and patient-reported percentage pain reduction, we computed the concordance correlation coefficient and performed Bland-Altman analysis.
RESULTS: Ninety-seven women in labor were enrolled in the study, most of whom were nulliparous, with a singleton fetus and in spontaneous labor. The concordance correlation coefficient with patient-reported percentage pain reduction was 0.76 (95% CI 0.6 to 0.8) and 0.77 (95% CI 0.6 to 0.8) for the visual analog and numerical rating scale, respectively. The Bland-Altman mean difference between calculated percentage pain reduction and patient-reported percentage pain reduction for the visual analog and numerical rating scales was -2.0% (limits of agreement at 29.8%) and 0 (limits of agreement at 28.2%), respectively.
CONCLUSION: The agreement between calculated percentage pain reduction from a visual analog or numerical rating scale and patient-reported percentage pain reduction in the context of labor epidural analgesia was moderate. The difference could range up to 30%. Patient-reported percentage pain reduction has advantages as a measurement tool for assessing pain management for childbirth but differences compared with other assessment methods should be taken into account.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Concordance correlation coefficient; Epidural analgesia; Labor pain; Pain scales

Mesh:

Year:  2017        PMID: 28284462     DOI: 10.1016/j.ijoa.2017.02.001

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN: 0959-289X            Impact factor:   2.603


  5 in total

1.  Effect of ondansetron for preventing postoperative nausea and vomiting after breast cancer surgery.

Authors:  Chunlei Li; Wenbin Cui; Panpan Song; Wang Liu; Xiaodong Wang; Qiang Yang
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Intra-Articular Injection of Amniotic Membrane and Umbilical Cord Particulate for the Management of Moderate to Severe Knee Osteoarthritis.

Authors:  Olivia G Mead; Leon P Mead
Journal:  Orthop Res Rev       Date:  2020-10-19

3.  Effect of ropivacaine and sufentanil in epidural labor analgesia.

Authors:  Xijiao Wen; Bowan Huang; Xin Liang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Effects of the addition of transcutaneous electrical stimulation to non-pharmacological measures in labor pain: study protocol for a randomized controlled trial.

Authors:  Naiara Toledo Dias; Patrícia Roberta Santos; Thais Alves Cândido; Rogério de Melo Costa Pinto; Ana Paula Magalhães Resende; Vanessa Santos Pereira-Baldon
Journal:  Trials       Date:  2022-01-17       Impact factor: 2.279

5.  Passive Recharge Burst Spinal Cord Stimulation Provides Sustainable Improvements in Pain and Psychosocial Function: 2-year Results From the TRIUMPH Study.

Authors:  Timothy R Deer; Steven M Falowski; Gregory A Moore; J Kelby Hutcheson; Isaac Peña; Kenneth Candido; Eric G Cornidez; von Und Zu Fraunberg; Bram Blomme; Robyn A Capobianco
Journal:  Spine (Phila Pa 1976)       Date:  2022-04-01       Impact factor: 3.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.